many people take medications called SSRIs
2020年2月28日 日常The field of customizing drug therapies based on an individual’s DNA, known as pharmacogenomics, is only in its infancy right now. But as time passes and more and more positive results emerge, personalized medicine will become standard practice. These efforts advertise the advent of personalized medicine, in which drugs and drug combinations are uniquely optimized for each individual’s unique genetic makeup. Scientific research doesn’t yet take into account the influence of genes on an individual’s health and well-being. What the past and the drive pulley manufacturers present teach us is that the universal approach to medicine hasn’t proved to be the best solution yet.
Presently, many people take medications called SSRIs, or selective serotonin reuptake inhibitors, for a host of psychiatric disorders, and many of the medications are metabolized by enzymes whose activity can be identified through testing.Pharmaceutical experts argue that personalized medicine offers many benefits over the traditional approach. Furthermore, this information allows for efficient drug development, knowing exactly how the liver metabolizes certain drug components, which in turn results in more accurate and cost-effective therapies, tailor-made based on individual genetic backgrounds without the need to cover as wide a base as possible to ensure compatibility. It combines the knowledge of pharmacology and that of genomics.
All in all, pharmacogenomics allows physicians to improve the quality of health care through precise diagnostics and personalized medicine, saving valuable time and money spent on unnecessary tests or ineffective treatments while providing patients with a better experience through better assimilation and less side effects.Pharmacogenomics has quite a lot of applications in illnesses such as cancer, cardiovascular disorders, depression, bipolar disorder, attention deficit disorders, HIV, tuberculosis, asthma, and diabetes. In doing this, it intends to develop the means to optimize drug therapy, with respect to the patients’ genotype, to ensure maximum efficacy with minimal adverse effects
Presently, many people take medications called SSRIs, or selective serotonin reuptake inhibitors, for a host of psychiatric disorders, and many of the medications are metabolized by enzymes whose activity can be identified through testing.Pharmaceutical experts argue that personalized medicine offers many benefits over the traditional approach. Furthermore, this information allows for efficient drug development, knowing exactly how the liver metabolizes certain drug components, which in turn results in more accurate and cost-effective therapies, tailor-made based on individual genetic backgrounds without the need to cover as wide a base as possible to ensure compatibility. It combines the knowledge of pharmacology and that of genomics.
All in all, pharmacogenomics allows physicians to improve the quality of health care through precise diagnostics and personalized medicine, saving valuable time and money spent on unnecessary tests or ineffective treatments while providing patients with a better experience through better assimilation and less side effects.Pharmacogenomics has quite a lot of applications in illnesses such as cancer, cardiovascular disorders, depression, bipolar disorder, attention deficit disorders, HIV, tuberculosis, asthma, and diabetes. In doing this, it intends to develop the means to optimize drug therapy, with respect to the patients’ genotype, to ensure maximum efficacy with minimal adverse effects
コメント